/

Ichnos Glenmark Innovation

Developing multispecific antibodies for treating cancer and complex diseases.

BiotechnologyPharmaceuticals iginnovate.com ↗

Company facts

Founded: 2019
Employees: 150
Headquarters: United States
Type: Private
Funding: Corporate Round · $171M · 2024